Results 131 to 140 of about 17,026 (178)
Some of the next articles are maybe not open access.
Treatment of Esophageal Spirocercosis With Milbemycin Oxime
Veterinary Parasitology, 2008Six medium sized mixed breed dogs treated with milbemycin oxime (11.5mg on days 0, 7 and 28 and then monthly) stopped shedding Spirocerca lupi ova after 3-44 days. There was no evidence of subsequent shedding in repeated tests (about 5/dog) carried out from 31 to 133 days after initiation of treatment.
R C Krecek
exaly +3 more sources
Veterinary Parasitology, 2014 Angiostrongylus vasorum is an increasingly reported parasite in Europe that develops in dogs after ingestion of infective third stage larvae (L3) that reside in gastropod molluscs which are needed to complete the parasite's life-cycle.
Manuela Schnyder +2 more
exaly +2 more sources
Efficacy of milbemycin oxime in chemoprophylaxis of dirofilariasis in cats
American Journal of Veterinary Research, 1992Summary Although cats are less susceptible to infection with Dirofilaria immitis than are dogs, the possibility of severe consequences from infection or adulticidal treatment renders preventive treatment a desirable alternative in endemic areas. To evaluate the efficacy of milbemycin oxime as a chemoprophylactic agent in cats, 48 cats were inoculated ...
V A, Stewart, D I, Hepler, R B, Grieve
openaire +2 more sources
Acute Toxicity of Milbemycin Oxime in Mice
2010 4th International Conference on Bioinformatics and Biomedical Engineering, 2010Milbemycin oxime, isolated from the fermentation of Streptomyces hygroscopicus var. aureolacrimosus, is effective to parasites such as heartworm larvae, adult hookworm and mites. Kunming mice were selected for the acute toxicity study. The animals exposed to milbemycin oxime by single intragastric administration.
Qianqian Xu +5 more
openaire +1 more source
Treatment of Baylisascaris procyonis infections in dogs with milbemycin oxime
Veterinary Parasitology, 2005An examination was made as to the ability of Sentinel Flavor Tabs (milbemycin oxime/lufenuron) to treat Baylisascaris procyonis infections in dogs. The study was designed as a critical trial and included five naturally infected dogs and two dogs that were experimentally infected.
Dwight D, Bowman +5 more
openaire +2 more sources
Notice of Retraction: Mutagenic Action of Milbemycin oxime
2011 5th International Conference on Bioinformatics and Biomedical Engineering, 2011The objective of this study was to determine mutagenicity of milbemycin oxime by Ames, micronucleus and sperm malformation tests. In the Ames assay, four genotypic variants of the Salmonella strains (TA97, TA98, TA100 and TA102) carrying mutations in several genes were used.
Mingli Qu, Jichang Li, Wensheng Xiang
openaire +1 more source
Effects of milbemycin oxime on adult hookworms in dogs with naturally acquired infections
American Journal of Veterinary Research, 1990SUMMARY Previous work indicated that adult Ancylostoma caninum can be removed from experimentally infected dogs, using a formulation of milbemycin oxime at dosage of 0.5 mg/kg of body weight. To determine the efficacy of this treatment in dogs naturally infected with adult hookworms, 24 mixed-breed dogs with patent hookworm infections were purchased ...
D D, Bowman, R C, Johnson, D I, Hepler
openaire +2 more sources
Clinical efficacy of milbemycin oxime in the treatment of generalized demodicosis in adult dogs
Journal of the American Veterinary Medical Association, 1993Summary Thirty adult dogs with chronic generalized demodicosis were treated with oral administration of milbemycin oxime (0.52 to 3.8 mg/kg oj body weight, q 24 h). Results oj skin scrapings were used to determine whether administration oj milbemycin should be continued or discontinued.
W H, Miller +3 more
openaire +2 more sources
Assessment of toxicosis induced by high-dose administration of milbemycin oxime in Collies
American Journal of Veterinary Research, 1991Summary Fifteen Collies, previously having mild reactions to ivermectin challenge (120 μg/kg of body weight; 20 times the recommended dosage level), were studied to evaluate the effects of milbemycin oxime administration at 5 and 10 mg/kg (10 and 20 times the manufacturer's recommended dosage).
W J, Tranquilli, A J, Paul, K S, Todd
openaire +2 more sources